A network‐based predictive gene expression signature for recurrence risks in stage II colorectal cancer

The current criteria for defining the recurrence risks of stage II colorectal cancer (CRC) are not robust; therefore, we aimed to explore novel gene signatures to predict recurrence risks and to reveal the underlying mechanisms of stage II CRC. First, the gene expression profiles of 124 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wen‐Jing, Wang, Hai‐Bo, Wang, Wen‐Da, Bai, Peng‐Yu, Lu, Hong‐Xia, Sun, Chang‐He, Liu, Zi‐Shen, Guan, Ding‐Kun, Yang, Guo‐Wang, Zhang, Gan‐Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943157/
https://www.ncbi.nlm.nih.gov/pubmed/31724326
http://dx.doi.org/10.1002/cam4.2642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943157/
https://www.ncbi.nlm.nih.gov/pubmed/31724326
http://dx.doi.org/10.1002/cam4.2642

Ejemplares similares